Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

19.800
-0.880-4.26%
Volume:6.73M
Turnover:134.08M
Market Cap:22.53B
PE:-15.76
High:20.500
Open:20.500
Low:19.730
Close:20.680
52wk High:27.280
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:0.95
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.256
ROE:-26.91%
ROA:-14.75%
PB:4.73
PE(LYR):-15.76
PS:6.39

Loading ...

Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a Dll3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (Epnecs)

THOMSON REUTERS
·
May 11

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

Zai Lab's Innovative Pipeline Nears Key Milestones, Unveiling Three Core Strengths for Potential Rebound

Stock News
·
May 08

Zai Lab's Net Loss Widens in Q1

MT Newswires Live
·
May 08

BUZZ-Zai Lab HK shares fall to 5-week low on weak Q1 results

Reuters
·
May 08

Stock Track | Zai Lab Plummets 5.68% Intraday Following Q1 Results Showing Revenue Decline and Widening Losses

Stock Track
·
May 08

Zai Lab Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Zai Lab: April 2026 Share Capital Stable; Equity Incentive Activity Generates USD 0.02 Million Without Dilution

Bulletin Express
·
May 07

Zai Lab Posts 6% Revenue Decline in Q1 2026; Pipeline Advances Offset Commercial Headwinds

Bulletin Express
·
May 07

Zai Lab Reports $99.6 Million in Total Revenue for Q1 2026

Stock News
·
May 07

Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates

THOMSON REUTERS
·
May 07

Zai Lab Ltd - Q1 2026 Total Revenues $99.6 Mln

THOMSON REUTERS
·
May 07

Zai Lab Ltd: Q1 EPS $-0.05

THOMSON REUTERS
·
May 07

Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
Apr 30

Zai Lab hits 286,000 new patients in 2025, keeps gender-pay parity and readies first global launch for 2028

Bulletin Express
·
Apr 28

再鼎医药2025年营收同比增长15.3%,全球业务与管线稳步扩张

Bulletin Express
·
Apr 28

Zai Lab publishes 2025 annual report

Reuters
·
Apr 28

ZAI LAB Calls 2026 AGM; Seeks Shareholder Nod on Director Re-election, KPMG Appointment and 10% Share Issuance/Buyback Mandates

Bulletin Express
·
Apr 28

Zai Lab announces annual shareholder meeting

Reuters
·
Apr 28

Zai Lab Sets 17 June 2026 AGM; Nine Director Re-elections, KPMG Appointment and 10% Share Mandates on Agenda

Bulletin Express
·
Apr 28